Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075113 | SCV001240724 | uncertain significance | Retinal dystrophy | 2018-08-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001365938 | SCV001562224 | uncertain significance | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2022-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 266 of the CRB1 protein (p.Cys266Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of CRB1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 866804). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRB1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV003455397 | SCV004178853 | uncertain significance | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455398 | SCV004178854 | uncertain significance | Pigmented paravenous retinochoroidal atrophy | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455396 | SCV004178855 | uncertain significance | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031187 | SCV004852075 | uncertain significance | Inborn genetic diseases | 2023-09-22 | criteria provided, single submitter | clinical testing | The c.796T>A (p.C266S) alteration is located in exon 3 (coding exon 3) of the CRB1 gene. This alteration results from a T to A substitution at nucleotide position 796, causing the cysteine (C) at amino acid position 266 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001833693 | SCV002090118 | uncertain significance | Leber congenital amaurosis | 2021-02-06 | no assertion criteria provided | clinical testing |